Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Axsome Therapeutics starts enrolment in MOMENTUM trial

MOMENTUM will only involve patients who experienced inadequate response to prior migraine treatments. Credit: r. nial bradshaw.



  • Axsome Therapeutics starts enrolment in MOMENTUM trial

Go Top